Developed by pioneers in the field of regenerative medicine, CLARIX cryopreserved umbilical cord allograft delivers the innate properties of amniotic tissue to facilitate the healing process across a range of surgical specialties.
With CLARIX, you’re able to transplant the innate biology to the surgical site, thus supporting a more structured healing environment, helping to manage regenerative healing, and facilitating your patient’s functional recovery. For more information on the unique biology of amniotic tissue and the science behind our products, read about our restorative tissue technology.
CLARIX delivers a more structured healing environment to support
EXPEDITED FUNCTIONAL RECOVERY
As our flagship product in the CLARIX family, CLARIX CORD 1K offers a superior product handling than standard amniotic membrane products. By utilizing the umbilical cord, CLARIX CORD 1K delivers a structured healing environment to the surgical wound site. CLARIX CORD 1K is up to 10x thicker than amniotic membrane (AM) which may increase longevity in the surgical site.
TissueTech was the first to recognize the unique power of umbilical cord, and has provided a product that is processed, stored and delivered to retain the innate properties of the native tissue.
Cryopreserved amniotic membrane (only) matrix for surgical applications, CLARIX 100, is a thinner alternative to CLARIX CORD 1K offering a potential advantage for use in minimally invasive procedures where access and space for application of a covering is limited.
The CLARIX 100 amniotic membrane graft offers larger size options (7.0cm x 7.0cm the largest available).
With a proven history of over 600,000 procedures, our umbilical cord allografts have successfully been utilized in a wide range of procedures with no known history of rejection and disease transmission1. The potential surgical applications cover numerous specialties.
CLARIX has been used extensively in orthopedic surgery in an array of procedures ranging from soft-tissue repair to nerve decompression, trauma and reconstruction, and arthroplasty.
While the number of successful applications is vast, each share common short-term and long-term goals that CLARIX is uniquely positioned to help support:
Maintaining an active lifestyle after suffering from a debilitating injury or joint disease can be difficult. CLARIX umbilical cord based allografts can be used intra-operatively to help facilitate healing of the soft tissues and joints.
CLARIX helps deliver the innate properties of placental birth tissue, to help manage adhesions in soft tissue injuries, supporting:
Scarring and inflammation are challenging to plastic surgery procedures. Amniox Medical’s umbilical cord allograft products can help improve outcomes by:
These results are possible through adjunct therapy and the use of our proprietary CRYOTEK® process that protects and preserves the tissue’s innate biology and structure, delivering the benefits of the natural tissue to the surgical site.
Scarring, discomfort and inflammation can lead to surgical complications.
CLARIX umbilical cord allografts have been used in numerous surgical procedures to:
*The techniques presented in this case study are for informational purposes only. Each surgeon must evaluate the appropriateness of the techniques based on his or her own medical training and expertise. Many variables including patient pathology, anatomy, and surgical techniques may influence procedural outcomes. While these clinical experiences are valid, the results are not necessarily typical, indicative or representative of all procedures in which TissueTech’s products are utilized. TissueTech’s product line has been used successfully in many patients by physicians of varying specialties during a variety of medical procedures, and complications, reactions, and/or adverse events are possible with any medical intervention. It is not possible to predict or warrant specific results, nor is it possible to guarantee patient and/or clinician satisfaction.
1 Data on file.